Fighting Blindness is a patient-led charity with a vision to cure blindness, support people experiencing sight loss and empower patients. We are the only Irish charity funding research into treatments for sight loss. To date, we have invested over €18 million in more than 100 research and clinical projects.
We provide professional counselling and therapeutic services for individuals and families living with vision impairment and blindness. We advocate for equity of access to timely and appropriate diagnosis, healthcare, therapies and support services and, through education and information provision, we work to empower the 247,000 children and adults in Ireland who are blind or visually impaired.
Over the past 35 years, we have grown from a small support group for families affected by retinitis pigmentosa (RP) to a nationally recognised brand.
Fighting Blindness promote and facilitate the development of therapies which are accessible to all patients affected by sight loss.
All research funded and engaged with aligns with the following principles, in terms of development and delivery:
- Diagnostics including genetics, phenotyping and retinal imaging
- Therapeutics such as gene therapy, novel drugs, retinal implants and optogenetics
- Cell technology and regenerative medicine
- Population studies
The Insight Counselling Service provides support for people and families who are living with sight loss. It is not just the individual who may need support, but his/her partner, children, extended family and friends. We work with all those affected, directly and indirectly, by sight loss.
As well as counselling services there are a number of peer to peer support services available, including the Visionaries School of the Arts, Exchange (Technology) Club and Mindfulness Group. For more on the support services please contact 01 674 6496.
Fighting Blindness advocates on behalf of everyone in Ireland affected by vision impairment. Working in partnership with stakeholder groups in the areas of health, science, industry and government to ensure that the patient voice is represented in all matters. We advocate for equitable access to existing treatments, novel therapies and appropriate care.